Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 65   

Articles published

GSK 1,393.58 +4.58 (0.33%)
price chart
Glaxo to Begin Hostile Offer for Human Genome Sciences
May 9 (Bloomberg) -- GlaxoSmithKline Plc will begin a hostile $2.6 billion tender offer this week for Human Genome Sciences Inc. after the U.S.
Glaxo's Melanoma Cocktail Slows Cancer in Study
May 17 (Bloomberg) -- GlaxoSmithKline Plc's combination of two experimental melanoma medicines slowed the progress of cancer with few skin complications in an early study, suggesting the combo may not have as many side effects as existing single-drug ...
Dabrafenib And Trametinib: Melanoma Drug Combo Shows Promise In Small Trial  Huffington Post
GlaxoSmithKline Leads Borrowers Selling Most Debt Since March
GlaxoSmithKline Plc, the U.K.'s largest drugmaker, sold $5 billion of bonds in its first dollar-denominated offering in four years as companies market the most U.S.
GlaxoSmithKline: Complied With Indian Rules for Drug Approval
BANGALORE - GlaxoSmithKline PLC said Thursday it was granted a waiver on conducting clinical trials in India for ambrisentan, its drug to treat pulmonary arterial hypertension, as local rules allow such a concession for drugs treating a "rare disease ...
Indian Drug Regulator Accused of Corruption and Collusion  Bloomberg
Glaxo Diabetes Drug Data Revealed Amid Hostile Takeover
May 25 (Bloomberg) -- GlaxoSmithKline Plc will reveal detailed results today on an experimental treatment for diabetes that's part of the reason for a $2.6 billion hostile takeover bid for Human Genome Sciences Inc., its partner on the drug.
GSK Says La. Can't Use Outside Attys In $12B Avandia Suit
Law360, New York (May 31, 2012, 4:30 PM ET) -- GlaxoSmithKline PLC urged a Louisiana state court on Thursday to bar the state's attorney general from using private attorneys to pursue a $12 billion Medicaid fraud suit over the safety risks of diabetes ...
Glaxo growth plan
Calcutta, May 14: GlaxoSmithKline Consumer Healthcare Ltd (GSKCH) - an associate of GlaxoSmithKline plc - is planning to introduce some of its global oral healthcare, nutrition and high-protein products in India.
Glaxo Scientist, Surgeon Targeting Historic British Hockey Gold
MacLeod, 27, also worked for GlaxoSmithKline Plc, the U.K.'s biggest drugmaker, as a sports scientist on its Lucozade energy drink.
Glaxo's Stiefel Unit Loses $1.5 Million Verdict on Buybacks
May 18 (Bloomberg) -- Stiefel Laboratories lost a $1.5 million jury verdict to a former employee who claimed the company bought back his stock at artificially low prices before its acquisition in 2009 by GlaxoSmithKline Plc. Timothy Finnerty won the ...
GlaxoSmithKline Launches Hostile Takeover Bid for Human Genome Sciences
GlaxoSmithKline Plc (NYSE: GSK), Britain's biggest drugmaker, will mount a $2.6 billion hostile takeover bid for Human Genome Sciences Inc. (NASDAQ: HGSI), the company announced Wednesday.